MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $739,400 | -52.3% | 5,063 | -24.6% | 0.00% | – |
| Q2 2023 | $1,551,627 | +388.5% | 6,717 | +412.4% | 0.00% | – |
| Q1 2023 | $317,603 | -23.5% | 1,311 | -8.4% | 0.00% | – |
| Q4 2022 | $415,000 | -53.5% | 1,431 | -85.4% | 0.00% | – |
| Q4 2019 | $892,000 | -5.9% | 9,787 | -11.0% | 0.00% | – |
| Q3 2019 | $948,000 | +40.4% | 10,996 | +70.9% | 0.00% | – |
| Q2 2019 | $675,000 | -25.6% | 6,436 | -11.1% | 0.00% | – |
| Q1 2019 | $907,000 | +12.4% | 7,241 | +1.2% | 0.00% | – |
| Q4 2018 | $807,000 | -14.9% | 7,156 | +61.7% | 0.00% | – |
| Q3 2018 | $948,000 | -56.2% | 4,426 | -42.7% | 0.00% | -100.0% |
| Q2 2018 | $2,162,000 | +107.9% | 7,728 | -13.2% | 0.00% | – |
| Q1 2018 | $1,040,000 | -44.1% | 8,905 | -56.1% | 0.00% | -100.0% |
| Q4 2017 | $1,859,000 | – | 20,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |